Status:
RECRUITING
Snus and Home Blood Pressure
Lead Sponsor:
University Hospital, Linkoeping
Conditions:
Blood Pressure
Dyslipidemias
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Snus is a type of snuff that is administered sublabially, that has not been studied regarding the effects on home blood pressure and metabolism on a longer time frame. The primary aim of this study is...
Detailed Description
Both elevated blood pressure (BP) and cigarette smoking increases the risk of cardiovascular disease. Nicotine, through effects on the nervous system and catecholamine release, increases BP and heart ...
Eligibility Criteria
Inclusion
- daily use (defined as at least once daily for at least 1 month) o snus
- the ability to use online questionnaires written and answered in Swedish
Exclusion
- simultaneous use of any other nicotine or tobacco product (including cigarette smoking, e-cigarettes, and nicotine replacement therapy)
- drug use (including cannabis)
- alcohol dependence
- known cardiovascular disease (including hypertension, previous myocardial infarction, stroke, peripheral arterial disease, or angina pectoris), kidney disease, hormonal disease (including diabetes mellitus) or eating disorder
- current or planned pregnancy.
Key Trial Info
Start Date :
October 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06019910
Start Date
October 9 2023
End Date
December 31 2024
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Health Care Center Cityhälsan Centrum
Norrköping, Sweden